NDC 67877-547 – Cefdinir
Cefdinir 125 mg/5mL · Powder, For Suspension · Oral
Product NDC67877-547
Product details
- Brand name
- Cefdinir
- Generic name
- Cefdinir
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- Powder, For Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA210534
- Marketed since
- February 20, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cephalosporin Antibacterial
Active ingredients
- Cefdinir 125 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 67877-547-88 | 100 mL in 1 BOTTLE (67877-547-88) | Feb 20, 2021 |
| 67877-547-98 | 60 mL in 1 BOTTLE (67877-547-98) | Feb 20, 2021 |
Other Cefdinir products
- 50090-4258 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-5811 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-6171 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-6417 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-7929 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-2735 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-3723 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-3725 Cefdinir Monohydrate 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 67877-548 Cefdinir 250 mg/5mL · Powder, For Suspension · Ascend Laboratories, LLC
- 76420-328 Cefdinir 250 mg/5mL · Powder, For Suspension · Asclemed USA, Inc.
- 76420-327 Cefdinir 125 mg/5mL · Powder, For Suspension · Asclemed USA, Inc.
- 65862-219 Cefdinir 250 mg/5mL · Powder, For Suspension · Aurobindo Pharma Limited